The global cell therapy market was valued at $4.79 billion in 2023 and is expected to reach $44.39 billion by 2034, growing at a compound annual growth rate (CAGR) of 22.69% from 2024 to 2034. This growth is driven primarily by the increasing focus on developing therapeutics for rare diseases.
Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5210
Cell therapy involves the delivery of modified cells outside of the body to treat or prevent diseases. The development of these therapies is at an early stage but holds significant promise for future therapeutic applications. Recent advancements in cell therapy research at government and university institutions worldwide have enhanced our understanding and application of cell-based treatments.
The integration of artificial intelligence (AI) in cell therapy can:
Recent Example:
In January 2023, CellVoyant, an AI-based biotechnology company, raised £7.6 million in early investment to accelerate the development of innovative cell therapies. The funding round was led by Octopus Ventures, with participation from Horizon Ventures, Verve Ventures, and Air Street Capital.
Stem cell therapy is used in various medical fields, including:
Despite its potential, the high cost of cell therapies presents a significant barrier. Treatments often exceed $400,000 per patient and can even surpass $1 million, raising concerns about affordability and accessibility for patients and healthcare systems worldwide.
CAR T-cell therapy is emerging as a promising treatment for blood cancers like leukemia and lymphoma. These therapies activate the immune system to target specific cancer antigens, minimizing damage to healthy tissues and offering long-term protection against cancer recurrence.
Recent Development:
In June 2024, Cytiva introduced the Sefia next-generation manufacturing platform to streamline the production of CAR T-cell therapies, enhancing efficiency and reducing costs for pharmaceutical companies.
Autologous therapy, which uses a patient’s own cells, dominated the market in 2023 due to its lower risk of immunological rejection and customization potential. It has been effective in treating burns, wounds, and inflammatory conditions.
Recent Example:
In April 2024, Aspen Neuroscience, Inc. reported the first patient dosage in a clinical trial using autologous therapy to replace dopaminergic neurons in Parkinson’s disease patients.
North America, particularly the U.S., leads the global cell therapy market due to its advanced healthcare infrastructure and focus on cancer research. The U.S. government’s strategic investments in science and research further contribute to this market’s growth.
Read Also: https://www.healthcarewebwire.com/microrna-market-size/
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/cell-therapy-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5210
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The rheumatoid arthritis drugs market size achieved a value of USD 17.87 billion in 2023 with this trajectory, it is… Read More
The ambulatory surgical centers market accounted for USD 94.57 billion in 2022 and is predicted to increase to USD 167.1… Read More
The global dental services market accounted for USD 432.1 billion in 2022 and is expected to hit US$ 699.7 billion… Read More
The cell and gene therapy manufacturing market size is estimated for US$ 3,755.4 million in 2022 to reach an estimate… Read More
The global CAR T-Cell therapy market is estimated to grow from USD 3.87 billion in 2022 at 29.8% CAGR (2023-2032)… Read More
Overview The automotive electronic stability control system market was valued at USD 40.65 billion in 2022 and is expected to… Read More